Filiz Kibar
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
- Microbiology top 10%
-
- Infections and bacterial resistance 4
-
- Antifungal resistance and susceptibility 7
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 3
-
- Ocular Infections and Treatments 6
-
- Vaccine Coverage and Hesitancy 4
-
- Nail Diseases and Treatments 3
Filiz Kibar
46 papers receiving 383 citations
Peers
Comparison fields: 5 of 91
- Medical Laboratory Technology 19
- Molecular Medicine 51
- Applied Microbiology and Biotechnology 17
- Microbiology 36
- Endocrinology 29
Countries citing papers authored by Filiz Kibar
This map shows the geographic impact of Filiz Kibar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filiz Kibar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filiz Kibar more than expected).
Fields of papers citing papers by Filiz Kibar
This network shows the impact of papers produced by Filiz Kibar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filiz Kibar. The network helps show where Filiz Kibar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Filiz Kibar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 4 | |
| 11 | 2019 | 13 | |
| 12 | 2017 | 13 | |
| 13 | 2015 | 14 | |
| 14 | 2015 | 7 | |
| 15 | Characterization of Antibiotic Susceptibility of Brucella Spp Isolates with E-Test Method | 2015 | 11 |
| 16 | KAN KÜLTÜRLERİNDEN İZOLE EDİLEN CANDIDA TÜRLERİNİN DAĞILIMININ VE ANTİFUNGAL DUYARLILIKLARININ RETROSPEKTİF OLARAK DEĞERLENDİRİLMESİ | 2015 | 1 |
| 17 | Stenotrophomonas maltophilia Infections from 2007 to 2011 | 2013 | 2 |
| 18 | Comparison of PCR and Cultivation Methods to Determine the Incidence of Infections due to Mycoplasma Hominis and Mycoplasma Fermentans in Women Genitourinary Tract | 2013 | 2 |
| 19 | Hospital-Acquired Bloodstream Infections in Cancer Patients between 2005 and 2007 in a Turkish University Hospital. | 2010 | 1 |
| 20 | Nosocomial Candida Infections: Microbiological and Clinical Features | 2009 | 1 |
About Filiz Kibar
Filiz Kibar is a scholar working on Applied Microbiology and Biotechnology, Endocrinology and Molecular Medicine, having authored 48 papers that have together received 401 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (7 papers), Ocular Infections and Treatments (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Vaccine Coverage and Hesitancy (4 papers), Antibiotic Resistance in Bacteria (4 papers), Infections and bacterial resistance (4 papers), Nail Diseases and Treatments (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Medical Laboratory Technology (19 citations), Molecular Medicine (51 citations) and Applied Microbiology and Biotechnology (17 citations). Filiz Kibar has collaborated with scholars based in Türkiye, Czechia and United States. Frequent co-authors include Akgün Yaman, Sali̇h Çeti̇ner, Yeşim Taşova, Aslıhan Candevir, Behice Kurtaran, Ayşe Seza İnal, Özlem Görüroğlu Öztürk, Tamer İnal, Hasan Salih Zeki Aksu and Süheyla Kömür.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.